N.Y. Federal Bankruptcy Court Extends Stay of Litigation Against Purdue Pharma

NEW YORK — A New York federal bankruptcy court has extended a stay of litigation against OxyCotin maker Purdue Pharma L.P. through April 2020 pending the OxyCotin maker's Chapter 11 bankruptcy proceedings.

In a Nov. 6 order, Judge Robert D. Drain of the U.S. Bankruptcy Court for the Northern District of Ohio said that continuation of the active litigation “would result in irreparable harm to the debtors and their reorganization.”

Purdue filed a voluntary petition for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Southern District of New York on Sept. 15 following its agreement to settle thousands …